Glioblastoma (GB) stands out as the most prevalent and lethal form of brain cancer.
Although great efforts have been made by clinicians and researchers, no significant …

MicroRNAs are small, noncoding molecules of about twenty-two nucleotides with crucial
roles in both healthy and pathological cells. Their expression depends not only on genetic …

Although γδ T cells comprise a small population of T cells, they perform important roles in
protecting against infection and suppressing tumors. With their distinct tissue-localizing …

Simple Summary Glioblastoma is one of the most dangerous tumors of the central nervous
system, and still cannot be fully overcome. We still mainly rely on standard treatments …

Purpose: Outcomes for patients with glioblastoma (GBM) remain poor despite multimodality
treatment with surgery, radiation, and chemotherapy. There are few immunotherapy options …

Background Glioblastomas manipulate the immune system both locally and systemically,
yet, glioblastoma-associated changes in peripheral blood immune composition are poorly …

Background Molecular entities showing dysregulation in multiple cancers may hold great
biomarker or therapeutic potential. There is accumulating evidence that highlights the …

Glioblastoma multiforme (GBM) is a primary brain tumor known for its short survival time,
typically 14-18 months from diagnosis to fatality. Managing GBM poses significant …

Glioblastoma is one of the most lethal cancers with current therapeutic options lacking major
successes. This underlines the necessity to understand glioblastoma biology on other levels …

Brain tumors are a diverse collection of neoplasms affecting the brain with a high prevalence
rate in people of all ages around the globe. In this pathological context, glioblastoma, a form …